Balyasny Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-70,485
| Closed | -$2.66M | – | 2334 |
|
|
2021
Q1 | $2.66M | Buy |
+70,485
| New | +$2.66M | 0.01% | 777 |
|
|
2018
Q3 | – | Sell |
-34,268
| Closed | -$542K | – | 1899 |
|
|
2018
Q2 | $542K | Sell |
34,268
-156,971
| -82% | -$2.48M | ﹤0.01% | 1150 |
|
|
2018
Q1 | $3.29M | Sell |
191,239
-258,911
| -58% | -$4.45M | 0.01% | 689 |
|
|
2017
Q4 | $9.87M | Buy |
+450,150
| New | +$9.87M | 0.03% | 557 |
|
|
2017
Q2 | – | Sell |
-83,289
| Closed | -$3.01M | – | 1606 |
|
|
2017
Q1 | $3.01M | Sell |
83,289
-88,062
| -51% | -$3.18M | 0.01% | 681 |
|
|
2016
Q4 | $8.59M | Buy |
171,351
+111,351
| +186% | +$5.58M | 0.05% | 433 |
|
|
2016
Q3 | $3.15M | Sell |
60,000
-91,996
| -61% | -$4.83M | 0.02% | 567 |
|
|
2016
Q2 | $6.29M | Buy |
151,996
+51,746
| +52% | +$2.14M | 0.04% | 370 |
|
|
2016
Q1 | $4.07M | Sell |
100,250
-125,552
| -56% | -$5.1M | 0.02% | 447 |
|
|
2015
Q4 | $9.37M | Sell |
225,802
-110,365
| -33% | -$4.58M | 0.07% | 348 |
|
|
2015
Q3 | $5.17M | Buy |
+336,167
| New | +$5.17M | 0.04% | 431 |
|